Bloomage BioTechnology Corporation Limited (SHA:688363)

Market Cap	25.33B
Revenue (ttm)	4.82B
Net Income (ttm)	53.35M
Shares Out	478.36M
EPS (ttm)	0.11
PE Ratio	474.83
Forward PE	46.06
Dividend	0.11 (0.21%)
Ex-Dividend Date	Jul 14, 2025

Volume	2,134,397
Average Volume	2,978,528
Open	53.24
Previous Close	53.18
Day's Range	52.81 - 53.50
52-Week Range	42.51 - 69.50
Beta	0.74
RSI	39.17
Earnings Date	Oct 29, 2025

About SHA:688363

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under th...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2000
• Employees: 4,444
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688363

Financial Performance

In 2024, SHA:688363's revenue was 5.37 billion, a decrease of -11.61% compared to the previous year's 6.08 billion. Earnings were 174.27 million, a decrease of -70.59%.